SW
BNTX icon

SVB Wealth’s BioNTech BNTX Stock Holding History

SVB Wealth’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,783
Closed -$162K – 674
2025
Q1 		$162K Sell
1,783
-5
-0.3% -$560 0.01% 335
2024
Q4 		$204K Buy
+1,788
New +$204K ﹤0.01% 680
2023
Q4 		– Sell
-1,917
Closed -$208K – 888
2023
Q3 		$208K Buy
1,917
+8
+0.4% +$885 ﹤0.01% 733
2023
Q2 		$206K Buy
1,909
+18
+1% +$2.02K ﹤0.01% 816
2023
Q1 		$236K Sell
1,891
-232
-11% -$31.9K ﹤0.01% 825
2022
Q4 		$319K Sell
2,123
-25
-1% -$3.85K ﹤0.01% 724
2022
Q3 		$289K Buy
2,148
+260
+14% +$39.7K ﹤0.01% 705
2022
Q2 		$281K Buy
1,888
+1
+0.1% +$153 ﹤0.01% 587
2022
Q1 		$322K Sell
1,887
-49
-3% -$8.23K ﹤0.01% 568
2021
Q4 		$499K Buy
1,936
+125
+7% +$34.2K 0.01% 445
2021
Q3 		$494K Buy
1,811
+5
+0.3% +$1.59K 0.01% 600
2021
Q2 		$404K Buy
+1,806
New +$341K 0.01% 647
2021
Q1 		– Sell
-3,000
Closed -$245K – 932
2020
Q4 		$245K Buy
+3,000
New +$295K ﹤0.01% 687

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SVB Wealth's BNTX Position: Q2 2025 in Review

SVB Wealth sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 1,783 shares — an estimated $162K sold.

SVB Wealth first reported a position in BNTX in Q4 2020 and held it in 13 quarters. The position peaked at $499K in Q4 2021. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • SVB Wealth reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 1,783 BioNTech shares in Q2 2025, an estimated $162K.
  • SVB Wealth first reported a position in BioNTech in Q4 2020 and held it in 13 quarters.
  • SVB Wealth's BioNTech position peaked at $499K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.